| MeSH term | MeSH ID | Detail |
|---|---|---|
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| de Wolff FA et al. | Valproate induces urinary D-glucaric acid excretion. | 1981 | Lancet | pmid:6111706 |
| Edwards OM et al. | Changes in cortisol metabolism following rifampicin therapy. | 1974 | Lancet | pmid:4140269 |
| Krafft A et al. | Erythropoietic quality of maternal milk. | 1999 | Lancet | pmid:10475225 |
| Hu Q et al. | Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. | 2010 | Lab. Invest. | pmid:20065947 |
| Yoon J et al. | Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement. | 2010 | Korean J. Intern. Med. | pmid:21179286 |
| Okada M et al. | Hypophosphatemia induced by intravenous administration of Saccharated iron oxide. | 1983 | Klin. Wochenschr. | pmid:6843038 |
| Blaustein DA et al. | The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. | 2003 | Kidney Int. Suppl. | pmid:14531777 |
| Keven K et al. | Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. | 2005 | Kidney Int. | pmid:15954940 |
| Agarwal R | Is i.v. iron really superior in CKD patients not on dialysis? | 2006 | Kidney Int. | pmid:16957750 |
| Zager RA | Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. | 2005 | Kidney Int. | pmid:16164630 |
| Agarwal R | Proinflammatory effects of iron sucrose in chronic kidney disease. | 2006 | Kidney Int. | pmid:16609688 |
| Deicher R et al. | High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. | 2003 | Kidney Int. | pmid:12846772 |
| Agarwal R | Transferrin saturation with intravenous irons: an in vitro study. | 2004 | Kidney Int. | pmid:15327409 |
| Aronoff GR et al. | Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. | 2004 | Kidney Int. | pmid:15327417 |
| Zager RA et al. | Parenteral iron nephrotoxicity: potential mechanisms and consequences. | 2004 | Kidney Int. | pmid:15200421 |
| Sengoelge G et al. | Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. | 2004 | Kidney Int. | pmid:15200437 |
| Zager RA et al. | Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. | 2016 | Kidney Int. | pmid:27165818 |
| Agarwal R et al. | A randomized trial of intravenous and oral iron in chronic kidney disease. | 2015 | Kidney Int. | pmid:26083656 |
| Vikrant S | Optimum dosage regimen for iron sucrose. | 2007 | Kidney Int. | pmid:17625585 |
| Agarwal R et al. | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2007 | Kidney Int. | pmid:17622274 |
| Jaber BL | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2008 | Kidney Int. | pmid:18235527 |
| Lim R et al. | A permanent tan from iron. | 2008 | Kidney Int. | pmid:18340355 |
| Auerbach M and Al Talib K | Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. | 2008 | Kidney Int. | pmid:18274543 |
| Schaller G et al. | Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. | 2005 | Kidney Int. | pmid:16316358 |
| Van Wyck DB et al. | A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. | 2005 | Kidney Int. | pmid:16316362 |
| Zheng H et al. | Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. | 2006 | Kidney Int. | pmid:16395269 |
| Almilaji A et al. | Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. | 2014 | Kidney Blood Press. Res. | pmid:25571875 |
| Tanaka H et al. | [A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)]. | 1982 | Kansenshogaku Zasshi | pmid:6809855 |
| Higashi T et al. | [Relative Ga-67 image enhancement by iron-loading]. | 1984 | Kaku Igaku | pmid:6593479 |
| Furuno K et al. | Influence of dehydration and D-glucarate on distribution and excretion of kanamycin in rats. | 1977 | Jpn. J. Pharmacol. | pmid:916384 |
| Furuno K et al. | Effect of D-glucaric acid derivatives on stability of rat liver lysosomes and erythrocytes. | 1974 | Jpn. J. Pharmacol. | pmid:4463271 |
| Hinohara Y et al. | Glucuronic acid pathway in alloxan diabetic rabbits. (I). Urinary excretion of metabolites related to the glucuronic acid pathway. | 1974 | Jpn. J. Pharmacol. | pmid:4463273 |
| Tsuruoka T et al. | Inhibition of pulmonary metastases and tumor cell invasion in experimental tumors by sodium D-glucaro-delta-lactam (ND2001). | 1995 | Jpn. J. Cancer Res. | pmid:7737908 |
| Tsuruoka T et al. | Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001). | 1995 | Jpn. J. Cancer Res. | pmid:8567400 |
| Adhikary L and Acharya S | Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. | 2011 Jul-Sep | JNMA J Nepal Med Assoc | pmid:22922860 |
| Smith TG et al. | Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. | 2009 | JAMA | pmid:19809026 |
| Lynn S and McDaniel J | Managing severe anemia when the patient is a Jehovah's Witness. | 2013 | JAAPA | pmid:23610833 |
| Gorder V et al. | Treatment of restless legs syndrome with iron infusion therapy. | 2009 | JAAPA | pmid:19354112 |
| Yamamoto S et al. | Iatrogenic osteomalacia: report of two cases. | 2013 | J. UOEH | pmid:23475021 |
| Wang Y et al. | Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. | 2014 | J. Sci. Food Agric. | pmid:23716136 |
| Kaltwasser JP et al. | Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. | 2001 | J. Rheumatol. | pmid:11708414 |
| Kolodziejczyk J et al. | In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. | 2011 | J. Physiol. Biochem. | pmid:21086198 |
| Tutor-Crespo MJ et al. | Effect of antiepileptic drugs on the urinary excretion of porphyrins in non-porphyric subjects. | 2005 | J. Pharmacol. Sci. | pmid:16314692 |
| Bologa M et al. | Pregnancy-induced changes in drug metabolism in epileptic women. | 1991 | J. Pharmacol. Exp. Ther. | pmid:2033516 |
| Patel IH et al. | Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys. | 1981 | J. Pharmacol. Exp. Ther. | pmid:7229992 |
| Tanaka E et al. | Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene. | 1982 | J. Pharmacobio-dyn. | pmid:7097483 |
| Garnham JC et al. | The effect of repeated administration of diftalone on enzyme induction. | 1978 | J. Pharm. Pharmacol. | pmid:27604 |
| Oleson L and Court MH | Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. | 2008 | J. Pharm. Pharmacol. | pmid:18718121 |
| Latham AN | D-Glucaric acid as an index of hepatic enzyme induction by anticonvulsant drugs in man. | 1974 | J. Pharm. Pharmacol. | pmid:4151390 |
| Latham AN | Effect of in vitro changes in urinary pH on the enzymatic measurement and daily variation in excretion of D-glucaric acid. | 1975 | J. Pharm. Pharmacol. | pmid:239180 |